Equities research analysts at StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research report issued to clients and investors on Monday. The firm set a “sell” rating on the stock. Separately, Roth Capital reiterated a “buy” rating on shares of Bio-Path in a research report on Friday, March 17th. Bio-Path […]
StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note published on Saturday morning. The firm issued a sell rating on the stock. Separately, Roth Capital reiterated a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Price Performance Shares of BPTH stock opened at […]
Equities researchers at StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report issued on Thursday. The firm set a “sell” rating on the stock. Separately, Roth Capital reaffirmed a “buy” rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Performance Shares of NASDAQ:BPTH opened […]
Investment analysts at StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the stock. Separately, Roth Capital reaffirmed a “buy” rating on shares of Bio-Path in a research note on Friday, March 17th. Bio-Path Stock Performance NASDAQ BPTH […]
StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report report published on Tuesday morning. The brokerage issued a sell rating on the stock. Separately, Roth Capital reissued a buy rating on shares of Bio-Path in a research report on Friday, March 17th. Bio-Path Trading Up 2.7 % Shares of […]